Liquid crystal compound having difluoromethyleneoxy, liquid crystal composition and liquid crystal display device
US-2015376502-A1 · Dec 31, 2015 · US
US10214506B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10214506-B2 |
| Application number | US-201815871049-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 14, 2018 |
| Priority date | May 25, 2017 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure belongs to the technical field of organic synthesis and particularly relates to a preparation method for 2-((4R,6S)-6-bromomethyl-2-oxo-1,3-dioxane-4-yl)acetate. The 2-((4R,6S)-6-bromomethyl-2-oxo-1,3-dioxane-4-yl)acetate is a key chiral intermediate for preparation of statin antilipemic agents. In the present disclosure, the 2-((4R,6S)-6-bromomethyl-2-oxo-1,3-dioxane-4-yl)acetate is obtained by bromination and cyclization of 3-((substituted oxycarbonyl)oxy)-5-hexenoate as raw material with hypochlorite and bromide in an organic solvent in the presence of CO 2 . The method of the present disclosure has the advantages of readily available raw material, mild reaction conditions, easy operation, low cost, excellent atomic economy and less by-products, and is applicable to industrial production.
Opening claim text (preview).
What is claimed is: 1. A preparation method for 2-((4R,6S)-6-bromomethyl-2-oxo-1,3-dioxane-4-yl)acetate, characterized in that a chemical formula of the 2-((4R,6S)-6-bromomethyl-2-oxo-1,3-dioxane-4-yl)acetate (I) is wherein R is alkyl or cycloalkyl having 1 to 8 carbon atoms, or mono- or poly-substituted aryl or aralkyl, wherein 2((4R,6S)-6-bromomethyl-2-oxo-1,3-dioxane-4-yl)acetate (I) is prepared by bromination and cyclization of 3-((substituted oxycarbonyl)oxy)-5-hexenoate as raw material with hypochlorite sad bromide in an organic solvent in presence of CO 2 , according to following reaction route: wherein R and R′ are same or different alkyl or cycloalkyl having 1 to 8 carbon atoms, or mono- or poly-substituted aryl or aralkyl; M is alkali metal, alkaline earth metal or ammonium cation; wherein the hypochlorite is selected from one or more of ethyl hypochlorite, isopropyl hypochlorite and tert-butyl hypochlorite; the bromide is selected from one or more of potassium bromide, sodium bromide and ammonium bromide; and the organic solvent is selected from one or more of ethyl acetate, dichloromethane, tetrahydrofuran, methanol, acetic acid, N,N-dimethyl formamide, acetone and acetonitrile. 2. The preparation method according to claim 1 , wherein a mole ratio of the 3-((substituted oxycarbonyl)oxy)-5-hexenoate (II) to the hypochlorite to the bromide is 1:(1-5):(1-5); a reaction temperature is −60° C. to 50° C.; and a reaction time is 10 mins to 180 mins. 3. The preparation method according to claim 1 , wherein the hypochlorite is tert-butyl hypochlorite; the bromide is potassium bromide; and the organic solvent is dichloromethane. 4. The preparation method according to claim 2 , wherein the hypochlorite is tert-butyl hypochlorite; the bromide is potassium bromide; and the organic solvent is dichloromethane. 5. The preparation method according to claim 2 , wherein a mole ratio of the 3-((substituted oxycarbonyl)oxy)-5-hexenoate (II) to the hypochlorite to the bromide is 1:(1.5-2.5):(1.5-2.5); a reaction temperature is −40° C. to 25° C.; and a reaction time is 30 mins to 60 mins. 6. The preparation method according to claim 1 , wherein the CO 2 is under a pressure of 0.1 MPa to 1 MPa.
of carboxylic acid ester groups · CPC title
Formation or introduction of functional groups not provided for in groups C07B39/00 - C07B45/00 · CPC title
not condensed with other rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.